The Applications of AI in Drug Discovery
Andrew A. Radin, head of a Silicon Valley biomedical startup, will be talking about the company’s use of artificial intelligence to accelerate the discovery of first-in-class drugs.
Radin is co-founder and chief executive officer of twoXAR, which uses proprietary computational drug discovery platform to discover, screen, and prioritize novel drug candidates with potential applications in many disease areas.
The free talk is open to the public. The event will be filmed.
For more information about our AI and bioscience course offerings, please visit UCSC Silicon Valley Extension.
Friday, June 28, 2019 at 11:00am to 11:45am
1793 LAFAYETTE ST SUITE 120, SANTA CLARA, CA 95050, Suite 120 1793 La Fayette St., Santa Clara, CA 95050